Several of the remaining 21 genes not in the GS, such as MYH14, MED23, and ZFP36L1 in BRCA, and ZNF292, FUBP1, and DTX1 in CLL, had also been implicated in tumor development36,39–41. This evidence concerns the gene ZNF292 and neoplasm.